Home  About Us Board of Directors
|
|
NYSCF’s Board of Directors is made up of leaders in medicine, the arts and business. Their talents and experience, combined with an unwavering commitment to advancing stem cell research, guide the Foundation in realizing its mission to accelerate research through collaboration.
|
|
|
Roy Geronemus, M.D. (Chairman)
|
 Dr. Roy Geronemus, Director of the Laser & Skin Surgery Center of New York, is a Clinical Professor of Dermatology at the NYU Langone Medical Center where he has founded its laser program and served nine years as its Chief of Dermatologic and Laser Surgery. He is also the Director of the Skin/Laser Division in the Department of Plastic Surgery at the New York Eye & Ear Infirmary. He is presently the president of the American Society for Laser Medicine & Surgery and a past president of the American Society for Dermatologic Surgery. He graduated from Harvard University and pursued his medical education at the University of Miami School of Medicine. He trained in dermatology at the New York University Medical Center where he was the Chief Resident and subsequently underwent fellowship training in Mohs Micrographic Surgery and Cutaneous Oncology. He has received the ASLMS Ellet Drake award and will receive... |
|
Read more »
|
|
|
Susan L. Solomon (Chief Executive Officer)
|
 Susan L. Solomon is the Co-founder and Chief Executive Officer of The New York Stem Cell Foundation (NYSCF), which was established in 2005 to provide private support for human embryonic stem cell research. Ms. Solomon is on the Board of Directors of the Juvenile Diabetes Research Foundation in New York City. As an active health-care advocate she is also a member of NYAMR (New Yorkers for the Advancement of Medical Research) and the New York Council of the Joslin Diabetes Center. An attorney by training, Ms. Solomon practiced law with Debevoise & Plimpton before beginning a twenty-year career in new media, entertainment and investment banking. She was founding Chief Executive Officer of Sothebys.com, and has served as Chairman and Chief Executive Officer of Lancit Media Productions...
|
|
Read more »
|
|
 Marilyn G. Breslow was President, and Senior Portfolio Manager of W. P Stewart & Co., Inc., an investment advisory firm in New York City, where she worked from 1990 until May 2005. She was also the Manager and Director of their U.S. Mutual Fund. She worked extensively in the Netherlands and Austria, where she was the Manager of two mutual funds for Spaengler Bank. She was a General Partner of Concord Partners, the venture capital division of Dillon, Read & Co., from 1984 to 1990, and was also a Vice President of that investment bank. Prior to Dillon, Read & Co., she was Director of Worldwide Marketing Services at Polaroid Corporation in Boston, and was a management consultant and General Partner at ICF, Inc., and Peat, Marwick, Mitchell & Co., Inc. in Washington D.C.
She has been a member of the M.I.T. Council for the Arts since 1997...
|
|
Read more »
|
|
 In 2005, Mary Elizabeth Bunzel co-founded the New York Stem Cell Foundation (NYSCF) with Susan L. Solomon. In addition to NYSCF, she serves on the Board of Directors of the New York Chapter of the Juvenile Diabetes Research Foundation (JDRF) and has previously served as Chapter President. Ms. Bunzel is also the Senior State Leader in New York for JDRF International, acting as liaison for advocate efforts in New York City, Westchester and Long Island.
A former journalist who has written for newspapers throughout the United States and abroad, Ms. Bunzel also serves as a member of the Board of Trustees of the Nightingale-Bamford School in New York City and Kenyon College in Gambier, Ohio. She is married to Jeffrey H. Bunzel, who runs U.S. Equity Capital Markets for Credit Suisse First Boston. The Bunzels have four children.
|
|
Read more »
|
|
 Dr. Karen Burke is a dermatologist and research scientist. She received her PhD in biophysics from Cornell University, Ithaca, and her MD from New York University Medical College. She completed postdoctoral fellowships at Cornell University Medical College and The Rockefeller University, and residency in dermatology at the NYU Medical Center. She is in private practice in New York City and on the faculties of Mt. Sinai Medical Center and Cabrini Medical Center.
Dr. Burke has written numerous articles and four books. Her current research demonstrates the efficacy of topical and oral antioxidants inpreventing and reversing photoaging of the skin and in prevention of skin cancer...
|
|
Read more »
|
|
 David Carmel is Co-Founder of Carmel Asset Management, an investment fund managed similarly to the top university endowments. Formerly, heserved as Vice President for Business Development at StemCyte Inc., a leading cell therapy company with operations in the US, Taiwan, and India. Prior to joining StemCyte, he spent a year working on Proposition 71, the California Stem Cell and Cures Initiative, for which voters approved $3 billion in research funds.
While still in college, David co-founded Jumpstart, a national service program that pairs college students one-on-one with preschoolers needing individual attention. A decade later, Jumpstart employs 80 full time staff and engages 2,500 college students in service to more than 10,000 children in 60 communities across 22 states...
|
|
Read more »
|
|
 Chuck Close was born in Monroe, WA, in 1940. He graduated magna cum laude with a BA from the University of Washington, Seattle, and received a BFA and MFA, both with the highest honors, from the School of Art and Architecture, Yale University. He also studied at Akademie der Bildenen Kunste, Vienna, from 1964-65, while on a Fulbright Grant.
Chuck Close’s work has been the subject of more than 100 solo exhibitions including those at The Museum of Modern Art, New York; Los Angeles County Museum of Art; The Art Institute of Chicago; and the Centre Georges Pompidou (Centre Beaubourg), Paris. He has participated in more than 300 group exhibitions including Documenta 5, 1972 and 6, 1977, Kassel, Germany; the Whitney Museum of American Art Biennial Exhibition in 1969, 1977, 1979 and 1991; the Venice Biennial in 1993, 1995 and 2002; and the Carnegie International, Pittsburgh, in 1995.
In 1980, the Walker Art Center, Minneapolis, organized a major retrospective that traveled to four venues including...
|
|
Read more »
|
|
|
Alan is head of Global Compliance at Goldman Sachs. He serves as a
vice chair of the Business Practices Committee and an ex-officio member
of the Management Committee. Alan joined Goldman Sachs in 2004 as a
partner.
Prior to joining the firm, Alan worked as a partner at O’Melveny &
Myers since 1991, where he co-headed the White Collar and Regulatory
Defense Practice and the New York Litigation Group. Prior to this, he
was an assistant US attorney for the Southern District of New York for
nine years, where his last assignment was as the chief of the
Securities and Commodities Fraud Task Force.
Alan earned a BA in 1972 from Temple University, and both a PhD in 1976
and a JD, with highest honors, in 1979 from Rutgers University.
|
|
Read more »
|
|
 Mr. Eastman is a partner at Eastman & Eastman. He served as a Trustee of Smith College from 1989 to 1999, as well as co-chair of Smith College $400 million capital campaign. He currently serves as a Trustee of the American Museum of Natural History; Director of the American Society of Composers Authors and Publishers (ASCAP); Director of the National Music Publishers Association; and Director of Apple Corps Limited (Beatles). He served as Director of United Television, Inc. from 1985 to 2001 and BHC Communications, Inc. from 1989 to 2001 (Chris-Craft Industries). He is a member of the Council on Foreign Relations, as ell as the Board of Visitors of Columbia University Medical Center. Mr. Eastman earned a BA in 1961 from Stanford University and a JD from New York University Law School in 1964.
|
|
Read more »
|
|
 Carol B. Einiger is President of Post Rock Advisors, LLC, a private
investment advisory firm. She worked from 1973-1988 at The First
Boston Corporation, where she became a Managing Director and Head of
the Capital Markets and Short-Term Finance Departments, and from
1989-1992 at Wasserstein Perella & Co., Inc. as a Managing
Director. From 1992-1996, Ms. Einiger served as Chief Financial
Officer and then Acting President of the Edna McConnell Clark
Foundation. Beginning in 1996, she served for nine years as Chief
Investment Officer of The Rockefeller University until establishing
Post Rock Advisors in 2005.
Ms. Einiger received her BA from the University of Pennsylvania in 1970
and her MBA from Columbia Business School in 1973. She is a Director
of Boston Properties, Inc., a Director of the Lasker Foundation...
|
|
Read more »
|
|
 Paul Goldberger is the Architecture Critic for The New Yorker,
where since 1997 he has written the magazine’s celebrated “Sky Line”
column. He also holds the Joseph Urban Chair in Design and
Architecture at The New School in New York City. He began his career
at The New York Times, where in 1984 his architecture criticism
was awarded the Pulitzer Prize for Distinguished Criticism, the highest
award in journalism.
He is the author of several books, most recently his chronicle of the process of rebuilding Ground Zero, entitled UP FROM ZERO: Politics, Architecture, and the Rebuilding of New York, and Beyond the Dunes: A Portrait of the Hamptons,
a project done in partnership with the photographer Jake Rajs,
published in 2008. In the fall of 2009 the Yale University Press will
publish...
|
|
Read more »
|
|
 Dr. Zach W. Hall, a neurobiologist now retired, was from 2005-2007 the first President of the California Institute for Regenerative Medicine (CIRM), the state agency set up under Proposition 71 for funding stem cell research in California. Previously (1994-1997), he served as Director of the National Institute of Neurological Disorders and Stroke at the National Institutes of Health (NIH).
After leaving NIH, he was Executive Vice Chancellor at the University of California, San Francisco (UCSF), where his major responsibility was the development of the new 43 acre campus at Mission Bay. In 2001-2002, he was President and CEO of EnVivo Pharmaceuticals, Inc., a start-up biotechnology company for the discovery and development of pharmaceuticals for neurodegenerative disease. From 2002-2005, he was Senior Associate Dean for Academic Development and also Director of the Zilkha Neurogenetic Institute at the Keck School of Medicine of the University of Southern California. Dr. Hall has made fundamental contributions to...
|
|
Read more »
|
|
 Dr. David L. Levy is the global healthcare sector leader of PricewaterhouseCoopers. In this role, he drives the ongoing growth of the firm’s health related industries practice through member firms around the world, identifies opportunities to forge global alliances, and develops new business and delivery models as health challenges and solutions, science and innovation converge. Dr. Levy also directs PricewaterhouseCoopers’ Health Industries strategy and leads the New York Metro Health Industries practice.
Before joining PricewaterhouseCoopers in 2005, Dr. Levy had over 25 years experience as a practicing primary care physician, epidemiologist, occupational health and quality consultant, and successful healthcare executive. His extensive customer experience, which includes some of the nation’s largest integrated health systems and insurers, has allowed him to pioneer innovative solutions that improve quality and cost for all stakeholders in the delivery system – patients, providers and payers.
While at PricewaterhouseCoopers, he has driven many of the firm’s largest-scale initiatives...
|
|
Read more »
|
|
 Dr. Richard J. Massey was President and Chief Operating Officer of BioVeris Corporation and prior to that IGEN International, Inc. BioVeris was an integrated healthcare company, based in Gaithersburg, Maryland, that developed proprietary diagnostics and vaccines. BioVeris was publicly traded and resulted from the merger between IGEN International, Inc. and F. Hoffmann-La Roche Ltd. Dr. Massey was a co-founder of IGEN International, Inc.
Dr. Massey managed the research and development programs, intellectual property portfolio and operations at IGEN International, Inc. and BioVeris from 1982 to 2004. Prior to IGEN International, Inc., he was on the faculty of...
|
|
Read more »
|
|
 Michael A. Stocker MD served as a Corporate Executive Vice President of Wellpoint Inc. from December 2005 until April 2007. Previously, he served as President and Chief Executive Officer of Empire HealthChoice HMO, Inc., Wellchoice, and President of Cigna Healthplans. In addition to NYSCF, he is on the Boards of the Arthur Ashe Institute for Urban Health, HMS Holdings Corporation, and the New York State Stem Cell Science (NYSTEM) Funding Board. He has also served on the Board of the Citizens Budget Commission of New York and at Albert Einstein College of Medicine. He was recently appointed by Mayor Bloomberg as Chairman of the Board of the New York City Health and Hospitals Corporation (HHC).
Dr. Stocker was educated at the University of Notre Dame and received his MD from the Medical College of Wisconsin in 1968. He received his postgraduate training at the Mayo Clinic and the University of California and is board certified in Internal Medicine and Family Practice. Dr. Stocker also holds an MPH from the University of Michigan.
|
|
Read more »
|
|
|
Janet Felleman (Emeritus)
|
 Janet Felleman was recently appointed the New York State Parks Commissioner and chair of the New York City Region. Previously she was the CEO and President of American Show Advisors which creates, markets and develops trade shows and conferences. She was the founder and former CEO of Corporate Presentations, the corporate parent of LegalTech which was acquired by American Lawyer Media in 1998. Janet is a trustee of Central Synagogue and on the President’s Council of Prep for Prep.
|
|
Read more »
|
|
|
|
|
|
|
